These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23639270)

  • 21. Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis.
    Akel T; Lafferty J
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12508. PubMed ID: 29105209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on intravenous vernakalant in recent-onset atrial fibrillation.
    Duggan ST; Scott LJ
    Drugs Aging; 2011 Jun; 28(6):501-4. PubMed ID: 21639409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Caro M; Ferro A; Klein A; Trivi M; Giniger A
    Can J Cardiol; 2013 Oct; 29(10):1330.e13. PubMed ID: 23465347
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
    Saklani P; Skanes A
    Curr Cardiol Rev; 2012 Nov; 8(4):302-9. PubMed ID: 22920483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
    Camm AJ; Capucci A; Hohnloser SH; Torp-Pedersen C; Van Gelder IC; Mangal B; Beatch G;
    J Am Coll Cardiol; 2011 Jan; 57(3):313-21. PubMed ID: 21232669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD
    Expert Opin Investig Drugs; 2008 May; 17(5):805-10. PubMed ID: 18447605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
    Lévy S; Hartikainen J; Ritz B; Juhlin T; Carbajosa-Dalmau J; Domanovits H
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):283-292. PubMed ID: 33206300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.
    Costabel JP; Lambardi F; Aragón M; Campos R; Urdapilleta M; Ariznavarreta P; Vergara JM; Conde D
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):196-200. PubMed ID: 25469647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
    Torp-Pedersen C; Camm AJ; Butterfield NN; Dickinson G; Beatch GN
    Int J Cardiol; 2013 Jun; 166(1):147-51. PubMed ID: 22108512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic drugs for atrial fibrillation.
    Marinelli A; Capucci A
    Expert Opin Pharmacother; 2011 Jun; 12(8):1201-15. PubMed ID: 21323608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
    Simon A; Niederdoeckl J; Skyllouriotis E; Schuetz N; Herkner H; Weiser C; Laggner AN; Domanovits H; Spiel AO
    Europace; 2017 Feb; 19(2):233-240. PubMed ID: 28175295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.
    Müssigbrodt A; John S; Kosiuk J; Richter S; Hindricks G; Bollmann A
    Europace; 2016 Jan; 18(1):51-6. PubMed ID: 26056189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New antiarrhythmic drugs for the treatment of atrial fibrillation].
    Botto GL; Russo G; Mariconti B; Pentimalli F; Campana C
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):10S-15S. PubMed ID: 23096368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world Data on the Efficacy of Vernakalant for Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation.
    Cosin-Sales J; Loscos A; Peiró A; Sorando MR; Buendía F; Ruescas L
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):619-20. PubMed ID: 27131972
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
    Hinneburg I
    Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New antiarrhythmic drugs for treatment of atrial fibrillation].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2010; 126(19):2255-62. PubMed ID: 21086684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vernakalant for the conversion of atrial fibrillation of recent onset].
    Seoane L; Baranchuk A; Conde D
    Medicina (B Aires); 2015; 75(4):239-44. PubMed ID: 26339882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel agents for the acute conversion of atrial fibrillation: focus on vernakalant.
    Cialdella P; Pedicino D; Santangeli P
    Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):1-8. PubMed ID: 21235460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter.
    Mao ZL; Townsend RW; Gao Y; Wheeler JJ; Kastrissios H; Keirns J
    J Clin Pharmacol; 2012 Jul; 52(7):1042-53. PubMed ID: 21659624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.